A POTENTIALLY life-saving device is being developed by an IPEM member to help people with sepsis.
Antibiotics are the mainstay for the treatment of sepsis, which is a life-threatening condition that arises when the body's response to infection causes injury to its own tissues and organs. It can lead to multiple organ failure and death. As resistant bacteria develop, however, antibiotics may become progressively less effective. A number of pathogen reduction technologies (PRT) are used in order to help in the reduction of pathogen population present in the blood of sepsis patients.
To address this problem, a team co-supervised by IPEM member Professor Nick Donaldson at University College London, has combined modern optical components with conventional photosensitisers and developed an innovative prototype PRT device that promises to offer a meaningful reduction of plasma microbes. Potentially, it would enable conventional antimicrobial treatments to be effective once more.
Professor Donaldson was awarded an Innovation Grant of almost £10,000 by IPEM last year, which will enable the team to expand the scope of the existing prototype device. They will design and construct the first part of a custom clinical device suitable for human scale treatment. The device will aim to eradicate pathogens found in blood plasma, without damaging important plasma components.
Professor Donaldson was one of five recipients of almost £50,000 in Innovation Grants which were handed out by IPEM last year for their various projects.
The grants, of up to £10,000, are for the purchase of equipment or services to facilitate short term innovation and research projects. The grants are open to all full members and Fellows and the closing date for applications for the grants this year is Friday 25 August. You can find more information on the awards, the other recipients and how to apply here.
© Institute of Physics and Engineering in Medicine
Registered in England and Wales (No. 3080332)
Registered Charity (No.1047999)